Effects of canagliflozin on human myocardial redox signalling: clinical implications. (2021)
Attributed to:
The predictive value of molecular and imaging markers for future cardiovascular events and outcomes
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/eurheartj/ehab420
PubMed Identifier: 34293101
Publication URI: http://europepmc.org/abstract/MED/34293101
Type: Journal Article/Review
Volume: 42
Parent Publication: European heart journal
Issue: 48
ISSN: 0195-668X